Login / Signup

Reproducibility and replicability of high-frequency, in-home digital biomarkers in reducing sample sizes for clinical trials.

Chao-Yi WuZachary BeattieNora MattekNicole SharmaJeffrey KayeHiroko H Dodge
Published in: Alzheimer's & dementia (New York, N. Y.) (2021)
Reproducibility and replicability of digital biomarker analyses are feasible and encouraged to establish the reliability of findings.
Keyphrases
  • high frequency
  • transcranial magnetic stimulation
  • clinical trial
  • healthcare
  • phase ii